ShareHope Medicine Co., Ltd.

ShareHope Medicine Co., Ltd.

TTPEX:8403
18.90
TWD
0.00
(0.00%)
1.13EPS
16.09P/E
2.63BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
19.93
20.5
22.03
20.23
23
23.45
23.02
30.01
27.97
30.06
28.14
31.43
31.66
32.91
Basic EPS, GAAP
0.95
1.11
2.24
1.07
1.09
1.12
1.44
1.81
1.69
2.14
0.9
1.45
1.03
1.19
Free Cash Flow per Basic Share
0.54
-0.14
0.65
0.22
-1.09
-0.58
2.89
2.59
1.51
-4.66
-0.15
1.26
1.69
2.31
Dividend per Share
0.28
0.29
0.3
0.96
0.33
0.36
0.36
- -
0.75
0.43
0.45
0.39
0.5
- -
Book Value per Share
11.35
12.19
17.37
15.61
16.08
17.39
18.49
21.24
22.88
24.84
25.34
25.84
25.02
23.97
Tangible Book Value per Share
10.03
11
16.35
14.17
14.75
15.89
16.45
18.74
20.42
22.35
22.89
23.5
22.77
21.74
Basic Weighted Avg Shares
94
96
97
115
114
130
136
137
138
138
138
138
138
137
Sales/Revenue/Turnover
1,865
1,969
2,135
2,330
2,617
3,057
3,124
4,099
3,850
4,137
3,873
4,326
4,358
4,496
Operating Margin (%)
5.51
6.71
6.45
6.86
6.67
2.75
4.87
12.57
6.31
8.15
3.15
4.38
4.02
4.34
Depreciation Expense
81
82
96
100
111
138
202
216
305
307
321
308
268
256
Net Income, GAAP
89
106
217
123
124
146
195
248
233
294
125
200
142
162
Effective Tax Rate (%)
19.26
23.56
16.88
25.46
24.26
19.17
12.28
24.63
27.73
28.19
49.29
29.62
25.48
22.24
Profit Margin (%)
4.78
5.4
10.15
5.29
4.75
4.77
6.24
6.04
6.04
7.11
3.22
4.63
3.25
3.61
Working Capital
1,006
428
818
550
470
1,173
978
1,527
1,683
1,463
1,275
1,532
1,569
1,487
LT Debt
478
146
135
189
172
265
221
395
725
1,494
1,456
1,204
1,185
1,187
Total Equity
1,181
1,326
1,881
1,966
2,047
2,562
2,701
3,579
3,883
4,099
3,955
3,981
3,832
3,697
Return on Invested Capital (%)
5.11
5.08
5.27
5.05
5.03
1.82
3.83
9.41
3.74
4.23
0.96
2.04
2.18
2.88
Return on Capital (%)
5.62
5.66
10
5.46
5.18
5.83
6.87
3.59
5.83
6.51
3.56
5.22
3.57
3.68
Return on Common Equity (%)
8.45
9.41
14.78
6.92
6.77
6.91
8.01
9.13
7.67
8.95
3.61
5.68
4.05
4.76

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
614
622
587
LT Borrowings
812
807
787
LT Finance Leases
373
358
401
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
138
138
138
Market Capitalization
3,214
3,062
2,629

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,132
3,084
3,110
Cash, Cash Equivalents & STI
1,578
1,523
1,537
Accounts Receivable, Net
1,165
1,170
1,157
Inventories
292
298
324
Total Current Liabilities
1,564
1,530
1,622
Payables & Accruals
- -
- -
- -
ST Debt
614
622
587
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.92%
1.49%
-3.74%
Free Cash Flow
-278.49%
-295.63%
33.78%
Net Income, GAAP
2.99%
-1.18%
-29.17%
Sales/Revenue/Turnover
7.91%
1.49%
0.74%
Total Cash Common Dividend
- -
- -
27.27%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
973
1,092
1,150
1,112
4,326
2025
1,052
1,073
1,107
1,126
4,358
2026
1,077
1,186
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.18
0.51
0.12
0.64
1.45
2025
0.23
0.2
0.23
0.38
1.03
2026
0.13
0.45
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.39
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
- -

Company Description

CEO
Hung Jen Yang
Full Time Employees
118
Sector
Distribution services
Industry
Medical distributors
Address
No. 168, Ching-Kuo Road Taoyuan TP Taiwan 330
IPO Date
Dec 24, 2008
Business
ShareHope Medicine Co., Ltd. ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan, specializing in health management and operations; human resource dispatch of professional medical staff including physicians, pharmacists, nurse practitioners, and medical technologists; provision of medical, pharmaceutical, and health devices; rental of medical instruments and equipment; long-distance health care; and telemedicine services. The company offers additional core products and services through its subsidiaries and business units, such as generic drugs, medical supplies, and dietary supplements from Macro Global Corporation; preventive medicine including genetic testing and health risk management from Pregetic Medical Health Co., Ltd.; chain pharmacy operations and community health services from YES Chain Pharmacy, which includes nearly 100 locations nationwide; health check-up and diagnostic services from Harvard Health Clinic, featuring precision preventive medicine and JCI-accredited facilities; medical information software from Techgroup Information Co., Ltd.; digital health platforms and smart medical systems from Digimed Co., Ltd. and SmartMedzone Co., Ltd.; rehabilitation services from Sheng Yo Rehabilitative Technologies, Inc.; and dialysis treatments integrated across its ecosystem. It operates primarily in Taiwan, with a focus on the Greater Taipei area, Taoyuan, and southern regions, targeting healthcare institutions, clinics, pharmacies, corporations for occupational health, and community patients; the company maintains partnerships with major clients including TSMC, Pegatron Corp., and Min-Sheng General Hospital. Founded in 2003 by Hung-Jen Yang and headquartered in Taoyuan City, Taiwan, ShareHope Medicine was listed on the Taipei Exchange (OTC) on March 1, 2011, and has expanded its business landscape to include cloud procurement, medical supplies manufacturing, e-commerce, long-term care, and digital transformation initiatives as a resource integrator in the healthcare ecosystem. Recent developments include its strategic investment in YES Chain Pharmacies to promote digital pharmacy models and expand chain operations; alliance with YES and MedzoneAsia E-commerce to establish a medical e-commerce procurement platform for pharmaceutical outsourcing and supply chain integration; acquisition of Taoyuan Chateau De Chine Hotel property to develop a smart medical city called Smart Medical Mall, incorporating elite physicians from Min-Sheng Hospital, cloud electronic medical records, joint practice teams, and intelligent eldercare residences; expansion of Harvard Health Check-Up locations with cross-industry collaborations; growth in hemodialysis centers serving Taiwan's high-prevalence dialysis patient population exceeding 94,000; and advancements in preventive medicine, equipment leasing with biomedical consulting, and smart pharmacy initiatives through the Institute for Information Industry.